Congress trades in Emergent BioSolutions (EBS)
Healthcare · Drug Manufacturers - Specialty & Generic
1 member of Congress has disclosed 1 trade in Emergent BioSolutions (EBS) since 2024: 0 buys and 1 sale. The most recent was disclosed on Jan 10, 2025.
- Trades disclosed
- 1
- Members trading
- 1
- Buys / sells
- 0 / 1
- Reported value
- $1K–$15K
Who traded EBS
MemberBuysSalesLast disclosed
- Rep. Steve Cohen (D-TN-9)0 buys · 1 sale01Jan 10, 2025
All trades
DisclosedTradeAmount
- Jan 10, 2025$1K–$15K
Rep. Steve Cohen (D-TN-9)
Sold (full) Emergent BioSolutions EBS
$1K–$15K · Traded Dec 11, 2024 · disclosed Jan 10, 2025
From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.